Acceder Registro /

Enrique Ortega Forte

Buscador

Ortega E, Yellol JG, Rothemund M, Ballester FJ, Rodríguez V, Yellol G, Janiak C, Schobert R, Ruiz J. A new C,N-cyclometalated osmium(ii) arene anticancer scaffold with a handle for functionalization and antioxidative properties. Chem Commun (Camb). 2018 Oct 2;54(79):11120-11123. doi: 10.1039/c8cc06427j. PubMed PMID: 30204166.
AÑO: 2018; IF: 6.164
Autores:
Ballester FJ, Ortega E, Porto V, Kostrhunova H, Davila-Ferreira N, Bautista D, Brabec V, Domínguez F, Santana MD, Ruiz J. New half-sandwich ruthenium(ii) complexes as proteosynthesis inhibitors in cancer cells. Chem Commun (Camb). 2019 Jan 25;55(8):1140-1143. doi: 10.1039/c8cc09211g. Epub 2019 Jan 11. PubMed PMID: 30631876.
AÑO: 2019; IF: 5.996
Autores:
González JJ, Ortega E, Rothemund M, Gold M, Vicente C, de Haro C, Bautista D, Schobert R, Ruiz J. Luminescent Gold(I) Complexes of 1-Pyridyl-3-anthracenylchalcone Inducing Apoptosis in Colon Carcinoma Cells and Antivascular Effects. Inorg Chem. 2019 Oct 7;58(19):12954-12963. doi: 10.1021/acs.inorgchem.9b01901. Epub 2019 Sep 24. PubMed PMID: 31550148.
AÑO: 2019; IF: 4.825
Ortega E, Zamora A, Basu U, Lippmann P, Rodríguez V, Janiak C, Ott I, Ruiz J. An Erlotinib gold(I) conjugate for combating triple-negative breast cancer. J Inorg Biochem. 2020 Feb;203:110910. doi: 10.1016/j.jinorgbio.2019.110910. Epub 2019 Oct 30. PubMed PMID: 31683128.
AÑO: 2020; IF: 4.155
Ballester FJ, Ortega E, Bautista D, Santana MD, Ruiz J. Ru(ii) photosensitizers competent for hypoxic cancers via green light activation. Chem Commun (Camb). 2020 Sep 14;56(71):10301-10304. doi: 10.1039/d0cc02417a. Epub 2020 Aug 5. PubMed PMID: 32756717.
AÑO: 2020; IF: 6.222
Autores:

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R